Cargando…
Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS
Objectives: To assess differences in the use of analgesics, sedatives and neuromuscular-blocking agents (NMBA) in patients with acute respiratory distress syndrome (ARDS) due to COVID-19 or other conditions. Methods: Retrospective observational cohort study, single-center tertiary Intensive Care Uni...
Autores principales: | Ego, Amédée, Peluso, Lorenzo, Gorham, Julie, Diosdado, Alberto, Restuccia, Giovanni, Creteur, Jacques, Taccone, Fabio Silvio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624865/ https://www.ncbi.nlm.nih.gov/pubmed/34835518 http://dx.doi.org/10.3390/microorganisms9112393 |
Ejemplares similares
-
How to Manage Withdrawal of Sedation and Analgesia in Mechanically Ventilated COVID-19 Patients?
por: Ego, Amédée, et al.
Publicado: (2021) -
Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection
por: Moreau, Anthony, et al.
Publicado: (2020) -
Hyperventilation in Adult TBI Patients: How to Approach It?
por: Gouvea Bogossian, Elisa, et al.
Publicado: (2021) -
Effect of inotropic agents on oxygenation and cerebral perfusion in acute brain injury
por: Coppalini, Giacomo, et al.
Publicado: (2022) -
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)